Literature DB >> 17235510

Effect of ornithine alpha-ketoglutarate on glutamine pools in burn injury: evidence of component interaction.

L Cynober1, E Lasnier, J Le Boucher, A Jardel, C Coudray-Lucas.   

Abstract

BACKGROUND: Ornithine alpha-ketoglutarate (OKG) has proved to be efficient in restoring glutamine (Gln) pools which are strongly depleted in hypercatabolic patients. Since its two components, alpha-ketoglutarate (alphaKG) and ornithine (Orn), give rise to glutamate (Glu), they are both considered as Gln precursors. The aim of this study was to assess the relative contributions of Orn and alphaKG to Gln generation in a rat model of burn injury.
METHODS: Forty-eight young Wistar rats were scalded to give a 20% burn surface area. They were fasted for 24 h and then refed by enteral nutrition for 48 h by gavages with Osmolite (Abbott-Ross, 210 kcal/kg day(-1), 1.18 N/kg day(-1)) supplemented with either 5 g OKG/kg day(-1) (B-OKG), Orn (isomolar to OKG; B-Orn), alphaKG (isomolar to OKG; B-KG) or glycine (as an isonitrogenous control; B-Gly). Rats in the B-KG group also received glycine to make all the groups isonitrogenous. Amino acid concentrations were determined in plasma, muscles, jejunal mucosa and liver.
RESULTS: The alpha-KG-enriched diet had no effect on plasma Glu content or plasma and muscle Gln content compared with the burn-injured controls. The Orn-enriched diet significantly increased (p<0.01) muscle Glu and Gln contents but not plasma Gln content. In OKG-treated animals, plasma Gln as well as muscle Glu and Gln were significantly higher than in the control (p<0.01), alpha-KG-treated (p< 0.01) and Orn-treated (p<0.05 for muscle Gln and p<0.01 for plasma Gln) animals.
CONCLUSION: OKG was more efficient than Orn or alphaKG alone in restoring Gln pools in plasma and muscle, which is evidence of metabolic interaction between the two components of this molecule.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17235510     DOI: 10.1007/s00134-006-0511-0

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  17 in total

Review 1.  Amino acid metabolism in thermal burns.

Authors:  L Cynober
Journal:  JPEN J Parenter Enteral Nutr       Date:  1989 Mar-Apr       Impact factor: 4.016

2.  Kinetics of organ specific metabolism of a bolus injection into the jejunum of glutamine, alpha-ketoglutarate, ornithine and ornithine - alpha-ketoglutarate.

Authors:  S Winkler; T Hölzenbein; J Karner; E Roth
Journal:  Clin Nutr       Date:  1993-02       Impact factor: 7.324

3.  Ornithine alpha-ketoglutarate modulates tissue protein metabolism in burn-injured rats.

Authors:  J Le Boucher; C Obled; M C Farges; L Cynober
Journal:  Am J Physiol       Date:  1997-09

4.  Enteral administration of ornithine alpha-ketoglutarate or arginine alpha-ketoglutarate: a comparative study of their effects on glutamine pools in burn-injured rats.

Authors:  J Le Boucher; C Coudray-Lucas; E Lasnier; A Jardel; O G Ekindjian; L A Cynober
Journal:  Crit Care Med       Date:  1997-02       Impact factor: 7.598

5.  Action of ornithine alpha-ketoglutarate, ornithine hydrochloride, and calcium alpha-ketoglutarate on plasma amino acid and hormonal patterns in healthy subjects.

Authors:  L Cynober; C Coudray-Lucas; J P de Bandt; J Guéchot; C Aussel; M Salvucci; J Giboudeau
Journal:  J Am Coll Nutr       Date:  1990-02       Impact factor: 3.169

6.  Ornithine alpha-ketoglutarate metabolism after enteral administration in burn patients: bolus compared with continuous infusion.

Authors:  T Le Bricon; C Coudray-Lucas; N Lioret; S K Lim; F Plassart; L Schlegel; J P De Bandt; R Saizy; J Giboudeau; L Cynober
Journal:  Am J Clin Nutr       Date:  1997-02       Impact factor: 7.045

7.  Ornithine alpha-ketoglutarate counteracts thymus involution and glutamine depletion in endotoxemic rats.

Authors:  E Lasnier; C Coudray-Lucas; J Le Boucher; A Jardel; L Cynober
Journal:  Clin Nutr       Date:  1996-08       Impact factor: 7.324

8.  In vivo induction of insulin secretion by ornithine alpha-ketoglutarate: involvement of nitric oxide and glutamine.

Authors:  Christina Schneid; Jean-Pascal De Bandt; Luc Cynober; E Torres; Gérard Reach; Sylviane Darquy
Journal:  Metabolism       Date:  2003-03       Impact factor: 8.694

Review 9.  Arginine metabolism: nitric oxide and beyond.

Authors:  G Wu; S M Morris
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

Review 10.  Ornithine alpha-ketoglutarate as a potent precursor of arginine and nitric oxide: a new job for an old friend.

Authors:  Luc Cynober
Journal:  J Nutr       Date:  2004-10       Impact factor: 4.798

View more
  6 in total

1.  Ornithine alpha-ketoglutarate: could it be a new therapeutic option for sarcopenia?

Authors:  S Walrand
Journal:  J Nutr Health Aging       Date:  2010-08       Impact factor: 4.075

Review 2.  Disrupted Alpha-Ketoglutarate Homeostasis: Understanding Kidney Diseases from the View of Metabolism and Beyond.

Authors:  Lijing Guo; Shihua Chen; Liping Ou; Shangmei Li; Zhen-Nan Ye; Hua-Feng Liu
Journal:  Diabetes Metab Syndr Obes       Date:  2022-06-27       Impact factor: 3.249

3.  Efficacy and safety of ornithine alpha-ketoglutarate in heel pressure ulcers in elderly patients: results of a randomized controlled trial.

Authors:  S Meaume; J C Kerihuel; T Constans; L Teot; E Lerebours; J Kern; I Bourdel Marchasson
Journal:  J Nutr Health Aging       Date:  2009-08       Impact factor: 4.075

Review 4.  Alpha-Ketoglutarate as a Molecule with Pleiotropic Activity: Well-Known and Novel Possibilities of Therapeutic Use.

Authors:  Barbara Zdzisińska; Aleksandra Żurek; Martyna Kandefer-Szerszeń
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2016-06-20       Impact factor: 4.291

5.  Fibroblast pyruvate carboxylase is required for collagen production in the tumour microenvironment.

Authors:  Natalya N Pavlova; Francesco V Cimino; Simon Schwörer; Bryan King; Xin Cai; Gina M Sizemore; Craig B Thompson
Journal:  Nat Metab       Date:  2021-11-11

Review 6.  Year in review in Intensive Care Medicine, 2007. I. Experimental studies. Clinical studies: brain injury and neurology, renal failure and endocrinology.

Authors:  Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Johan Groeneveld; Goran Hedenstierna; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Philipp Metnitz; Jerôme Pugin; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2008-01-04       Impact factor: 17.440

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.